Analysis of Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Ciliary Body after Latanoprost-Reference-Cited by-同舟云学术

Analysis of Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Ciliary Body after Latanoprost

Published:2006-03-01 Issue:3 Volume:47 Page:953
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Oh Dong-Jin¹,Martin Jonathan L.²,Williams Adrienne J.²,Peck Rachel E.²,Pokorny Corinna²,Russell Paul³,Birk David E.⁴,Rhee Douglas J.⁵

Affiliation:

1. From the Laboratory for Molecular Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania; the2Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; the

2. From the Laboratory for Molecular Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania; the

3. Section on Aging and Ocular Disease, National Eye Institute, National Institutes of Health, Bethesda, Maryland; and the

4. Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.

5. From the Laboratory for Molecular Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania; the2Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; the4Department of Pathology, Anatomy and Cell Biology, Thomas Jef

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of artificial light with different spectral compositions on refractive development and matrix metalloproteinase 2 and tissue inhibitor of metalloproteinases 2 expression in the sclerae of juvenile guinea pigs;European Journal of Histochemistry;2024-06-27

2. Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork;European Journal of Pharmacology;2023-09

3. Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant;Investigative Opthalmology & Visual Science;2023-03-06

4. Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies;Journal of Ocular Pharmacology and Therapeutics;2023-02-01

5. Effects of selective EP2 receptor agonist, omidenepag, on trabecular meshwork cells, Schlemm’s canal endothelial cells and ciliary muscle contraction;Scientific Reports;2021-08-10